y.ndiaye
Submits third-party assay reports on material purchased directly. Based in Uppsala.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.69%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043423 | L-Glutathione (reduced) | WXT | WXT-2605-B3833 | Janoshik | 2026-Q3 | 97.86 | 6.66 | 93.4 | Buyer-sourced | 0 | FAIL |
| AX-2026-041745 | Cagrilintide | TFS | TFS-{CAT}-1681 | VendorInvestigate | 2026-Q2 | 98.59 | 4.51 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042534 | BPC-157 | HJ | HJ-2511-P5900 | Janoshik | 2026-Q2 | 99.72 | 3.26 | 95.3 | Buyer-sourced | 0 | PASS |
| AX-2026-041320 | ARA-290 | WWB | WWB-2511-S3009 | Janoshik | 2026-Q1 | 99.70 | 5.13 | — | Laboratory-retained | 0 | PASS |
| AX-2026-041235 | Retatrutide | WWB | WWB-2510-H1662 | Janoshik | 2026-Q1 | 99.13 | 4.71 | 98.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020785 | CJC-1295 (no DAC) | CPC | CPC-2509-L9867 | Janoshik | 2025-Q4 | 97.86 | 6.46 | 99.6 | Buyer-sourced | 1 | FAIL |
| AX-2025-019154 | LL-37 | SinoPep | SNP-2411-X3762 | Janoshik | 2025-Q1 | 98.65 | 2.63 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004683 | Semaglutide | Homopeptide | HOMO-2401-R3356 | Janoshik | 2024-Q2 | 98.72 | 2.49 | — | Buyer-sourced | 0 | PASS |